Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W1US
|
|||
Former ID |
DIB002003
|
|||
Drug Name |
PLECONARIL
|
|||
Synonyms |
Picovir; Pleconaril < Prop INN; SR-263843; SR-63843; VP-63843; Win-63843; 3-[3,5-Dimethyl-4-[3-(3-methylisoxazol-5-yl)propoxy]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 2 | [1] | |
Company |
ViroPharma
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H18F3N3O3
|
|||
Canonical SMILES |
CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F
|
|||
InChI |
1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3
|
|||
InChIKey |
KQOXLKOJHVFTRN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 153168-05-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Picornavirus Capsid protein VP1 (PicVir VP1) | Target Info | Modulator | [2], [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00031512) Pleconaril Enteroviral Sepsis Syndrome. U.S. National Institutes of Health. | |||
REF 2 | Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob Agents Chemother. 2005 Nov;49(11):4492-9. | |||
REF 3 | Treatment of picornavirus infections. Antiviral Res. 2002 Feb;53(2):83-98. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.